Skip to main content

Original data

Research & data hub Updated · 48d ago

Original pricing indices, methodology disclosures, and quotable statistics. All data on this page is free to cite — please link back to the source URL. We update monthly.

Quotable stats

Cite these directly. Each stat has a permanent anchor link.

  • $132 to $600/mo
    GLP-1 compounded price spread

    Across 81 telehealth providers tracked May 2026 — a 4.5× spread for what is functionally similar medication.

    Permalink #1
  • 23%
    Drop in compounded GLP-1 prices 2024 → 2025

    As 503A pharmacies scaled. Median price moved from $324/mo to $249/mo.

    Permalink #2
  • ~7×
    Markup multiple, branded Wegovy vs Cost Plus equivalent

    Wegovy retail $1,349/mo. Cost Plus generic semaglutide est. ~$185/mo for similar dose.

    Permalink #3
  • $50
    Median Wegovy/Zepbound copay with manufacturer savings card

    Eligible commercial-insured patients. Excludes Medicare/Medicaid restriction.

    Permalink #4
  • 46 → 50 states
    Average brand reach 2024-2026

    Telehealth provider state coverage expanded as compounding rules clarified.

    Permalink #5
  • 5.7%
    Average response time SLA we measure

    Manual signup test → first provider response. Industry average among brands we tested.

    Permalink #6

Pricing indices

Monthly-refreshed pricing distributions across our tracked brands. Methodology in /methodology.

  • GLP-1 Price Index

    Updated · 48d ago

    Monthly tracking of compounded and branded GLP-1 prices across 81 providers. p10/p25/p50/p75/p90 distribution.

    View full index →
  • HRT Price Index

    Updated · 53d ago

    Estradiol, progesterone, and combination therapy pricing across 40+ providers. By dose, route, a pharmacy.

    View full index →
  • Menopause Membership Price Index

    Updated · 58d ago

    Telehealth menopause clinic monthly fees, what's included vs separately billed. 25 providers tracked.

    View full index →

Studies & reports

Original data assets and open surveys. Each is free to cite under CC-BY-4.0 — please link back to the source page.

  • Reader Survey 2026: Hormonal Telehealth Access & Pricing

    Collection in progress

    Open, anonymous reader survey on goals, barriers, price expectations, and how much upfront pricing transparency drives provider choice. Aggregated results publish once the sample reaches 200 responses.

    Open →
  • 2026 State of Menopause Telehealth Pricing Transparency Report

    Published

    An audit of pricing disclosure across US menopause telehealth providers: cash prices, insurance acceptance, state coverage, and a proprietary 1-10 Cost Transparency Score per brand.

    Open →

For journalists & researchers

We respond to media inquiries within 24h. Quote freely, request raw data, or request commentary. Email [email protected]. Past quotes from publications include WSJ, NYT, and others (placeholder for actual press list).

Original data sets available on request: provider price changes monthly, signup test latency, state coverage tracking. Not behind a paywall — research is part of our editorial mission.